Budur Kumar has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Kumar Budur is the Chief Medical Officer of Harmony Biosciences Holdings, Inc., a pharmaceutical company focused on rare neurological diseases and the development of WAKIX (pitolisant) for narcolepsy. In Harmony's SEC filing context (CIK 0002009762) dated 2026-01-26, Budur is listed in the CMO role with one filing and no reported securities trades.
Role
Insider
Notability
35/100
Board memberships
Harmony Biosciences Holdings, Inc.
Awards & honors
Serves as Chief Medical Officer at Harmony Biosciences, overseeing medical strategy and clinical development.
Guides medical oversight for WAKIX (pitolisant) programs addressing narcolepsy and related disorders.
Contributes to regulatory strategy and medical affairs in a specialty pharmaceutical company focused on rare neurological diseases.
Kumar Budur is the Chief Medical Officer of Harmony Biosciences Holdings, Inc., a pharmaceutical company focused on rare neurological diseases and the development of WAKIX (pitolisant) for narcolepsy. In Harmony's SEC filing context (CIK 0002009762) dated 2026-01-26, Budur is listed in the CMO role with one filing and no reported securities trades.…
How many SEC Form 4 filings has Budur Kumar submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Budur Kumar's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
